AbbVie Inc

Common Name
AbbVie
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
55,000
Ticker
ABBV
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
AbbVie Inc. is a prominent biopharmaceutical company that focuses on developing innovative therapies addressing some of the world's most challenging diseases. Originating from a 2013 spinoff of Abbott...

AbbVie's GHG Emissions Data Preview

In 2024, AbbVie completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).

However, AbbVie has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into AbbVie's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of AbbVie amounted to 541,214 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2023, the total operational greenhouse gas (GHG) emissions of AbbVie decreased by 4.37%, showing that the company has made progress in taking action to reduce the climate impact of its operations.

AbbVie's Scope 1 Emissions Over Time

2018201920202021202220232024095 k190 k285 k380 ktCO2e0%-16%+39%-7%-4%-9%
  • Total Scope 1
  • Year-over-Year Change

What are AbbVie's Scope 1 emissions?

In 2024, the total Scope 1 emissions of AbbVie were 300,072 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Has AbbVie reduced its Scope 1 emissions over time?

Since 2018, AbbVie's Scope 1 emissions have decreased by 4.44%, reflecting a declining long-term trend in Scope 1 emissions over time.

Compared to the previous year (2023), AbbVie's Scope 1 emissions decreased by 8.59%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.

What are AbbVie's Scope 2 emissions?

In 2024, AbbVie reported Scope 2 greenhouse gas (GHG) emissions of 122,287 tCOâ‚‚e using the market-based method, and 241,142 tCOâ‚‚e using the location-based method.

Has AbbVie reduced its Scope 2 emissions over time?

Compared to the previous year (2023), AbbVie's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that AbbVie 's emissions have plateaued with no significant change in its energy consumption footprint.

What methodology does AbbVie use for Scope 2 reporting?

In 2024, AbbVie reported its Scope 2 emissions using the market-based method and using the location-based method.

AbbVie's Scope 2 Emissions Over Time

2018201920202021202220232024085 k170 k255 k340 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
Want Full Access to AbbVie's GHG Emissions Dataset?
Sign Up